Congestive heart failure is also called heart failure and is the pathophysiological state in which an abnormal cardiac function is responsible for decreased efficiency in the ability of the heart to pump blood.
This decreased efficiency and effectiveness leads to a decreased oxygen supply to tissues around the body and subsequent symptoms which can result in death.
In order to understand the relationship between pulmonary hypertension and congestive heart failure it is essential that you have a basic understanding of how the heart works.
The heart consists of four separate chambers. The top two chambers are called atria in the bottom two chambers are called ventricles. Blood enters the heart through the right atrium, passes through to the right ventricle where it is pumped out to the lungs through the pulmonary artery.
Here are the blood picks up oxygen and is carried back to the heart in through the left atrium through the pulmonary vein. The blood then travels into the left ventricle where the heart pumps it out through the aorta to the rest of the body.
Pulmonary hypertension is a diagnosis that is received when the blood pressure in the pulmonary artery, or the blood vessel that leads from the heart into the lungs, is higher than normal. The pressure in the pulmonary artery is usually lower compared to that pressure which is in the aorta.
Having a higher blood pressure in the pulmonary artery can create irrevocable damage to the lungs and cause the right ventricle to fail as it pumps against a greater pressure than it was designed to pump against.
Pulmonary hypertension can both cause congestive heart failure or be caused by congestive heart failure. Pulmonary hypertension is usually divided into a primary type and secondary type. Primary pulmonary hypertension has an origin of unknown etiology. In other words, it happens with no family history, no familial form and no primary disease.
Secondary pulmonary hypertension can be due from congenital heart disease, pulmonary embolism, collagen and vascular disorders, sarcoidosis, HIV or portal hypertension. Pulmonary hypertension can also be a result of blood clots, lung disease, heart disease and sleep disorders.
Pulmonary hypertension is suspected in an x-ray or echocardiogram indicates an enlargement of the right ventricle. A cardiac catheterization will allow a physician to diagnose pulmonary hypertension and determine the best treatment plan for your individual needs.
CAT scans, pulmonary function tests, exercise tests, perfusion lung scans, magnetic resonance imaging and blood tests will all be used to track the progress of the disease in its response to treatment.
Left untreated pulmonary hypertension will result in heart failure, blood clots and fluid buildup in the lungs and legs. Treatment options will include a variety of oral and inhaled medications which include diuretics to help rid the body of extra fluid which puts extra pressure on the heart, anticoagulants that reduces the risk of blood clots, calcium channel blockers, and a variety of other medications which can be delivered either orally or through an intravenous method in order to relieve shortness of breath and help ease the symptoms of pulmonary hypertension.
In the United States more than 3 million people have congestive heart failure. Individuals who suffer from congestive heart failure and pulmonary hypertension should avoid pregnancy, high altitude, decongestants, beta-blockers and nonsteroidal anti-inflammatory is because they place a large workload on the heart and lungs.
When patients with heart failure become unresponsive to combination of treatment protocols and physicians believe they are unlikely to survive one year they can be considered for a heart-lung transplantation.
They are not qualified candidates for heart transplants because of the pulmonary hypertension but may qualify for a heart lung transplants if there are underlying medical conditions do not rule them out.
Many senators now have one year survival rates that exceed 90% and five-year survival rates that hover around 70%.
Keep Your Heart Healthy!
Cardio Support contains ingredients that affect different aspects of cardiovascular health, including arterial integrity, blood health, heart muscle strength and better blood flow.
Additionally, the ingredients in Cardio Support overlap their abilities, to enhance one another’s effects, increasing long-term heart health and protection against degenerative disease.
Cardio Support is the only natural supplement that we are aware of which utilizes enteric coating technology to safely release the active ingredients in the stomach.
This delivery method not only protects the enzymes such as Nattokinase but also greatly enhances the efficacy of other ingredients present such as Resveratrol and L-Glutathione.
No other formula covers so many ‘angles’ to manage and protect your cardiovascular system, and yet Cardio Support is still natural with no known side effects.